Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2025
Request Sample Buy Now
Global Cell And Gene Therapy Supply Chain/Logistics Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2025

By Type Of Software Solution (Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System), By Mode Of Deployment (Cloud-Based Solution, On-Premises Solution), By Component (Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components), By Application Area (Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up), By End User (Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cell And Gene Therapy Supply Chain/Logistics Market Overview

• Cell And Gene Therapy Supply Chain/Logistics market size has reached to $1.41 billion in 2024

• Expected to grow to $2.44 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%

• Growth Driver: The Surging Demand For Cell And Gene Therapies Reshapes Supply Chain And Logistics

• Market Trend: Advancements In Technology Propel Cell And Gene Therapy Logistics

• North America was the largest region in 2024.

What Is Covered Under Cell And Gene Therapy Supply Chain/Logistics Market?

Cell and gene therapy supply chains and logistics refer to the processes and activities involved in efficiently and effectively managing the flow of materials, information, and resources needed to develop, manufacture, and distribute cell and gene therapies from their initial production to their final administration to patients. These services provide cutting-edge treatments to patients while maintaining the highest safety and efficacy standards throughout the supply chain.

The main types of software solutions are cell orchestration platforms, enterprise manufacturing systems, Inventory Management Systems, laboratory information management systems, logistics management systems, patient management systems, quality management systems, and tracking and tracing systems. A cell orchestration platform refers to a software or technological platform that facilitates the coordination, management, and integration of various processes and activities involved in cell therapy development, manufacturing, and delivery and is used to help streamline and automate tasks related to cell sourcing, manufacturing, quality control, logistics, patient tracking, and data management. They are deployed as a cloud-based solution; an on-premises solution in cryogenic shippers; cryogenic storage freezers; ultra-low freezers; cold chain management systems; shipment; storage medium; cryogenic packout kits; and other components. These solutions are used in applications such as donor eligibility assessment, sample collection, manufacturing, logistics, patient verification, and treatment follow-up by end users including biobanks, cell therapy labs, hospitals, research institutes, and commercial organizations.

Cell And Gene Therapy Supply Chain/Logistics Market Size and growth rate 2025 to 2029: Graph

What Is The Cell And Gene Therapy Supply Chain/Logistics Market Size 2025 And Growth Rate?

The cell and gene therapy supply chain/logistics market size has grown rapidly in recent years. It will grow from $1.41 billion in 2024 to $1.57 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to growth in prevalence of chronic diseases, efficient use of supply chain requirements, rise in maintenance the drug integrity, evolved regulatory frameworks, increased emphasis on risk mitigation and compliance

What Is The Cell And Gene Therapy Supply Chain/Logistics Market Growth Forecast?

The cell and gene therapy supply chain/logistics market size is expected to see rapid growth in the next few years. It will grow to $2.44 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to expansion of personalized medicine, development of cell-free therapies, growing prevalence of chronic diseases, growing global cell therapy manufacturing market, efficient use of supply chain requirements. Major trends in the forecast period include increased research and development expenditure, adoption of advanced technologies, favorable initiatives and programs for easier access, partnerships and collaborations between cell and gene therapy companies, supply chain providers, and logistics companies, providing of customizable services to support any point of patient identification.

The forecast of 11.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose critical challenges for U.S. therapies by restricting access to cryogenic shipping containers and temperature-monitoring devices imported from the Netherlands and Sweden, potentially compromising $2M+ cell therapy shipments. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Cell And Gene Therapy Supply Chain/Logistics Market Segmented?

1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System

2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution

3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components

4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up

5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization

Subsegments:

1) By Cell Orchestration Platform: Workflow Management, Scheduling And Coordination Tools

2) By Enterprise Manufacturing System: Production Planning And Control, Manufacturing Execution Systems (MES)

3) By Inventory Management System: Stock Tracking And Management, Inventory Forecasting And Optimization

4) By Laboratory Information Management System (LIMS): Sample Tracking And Management, Data Management And Reporting

5) By Logistics Management System: Route Optimization And Planning, Transportation Management

6) By Patient Management System: Patient Scheduling And Coordination, Data Management And Tracking Of Patient Outcomes

7) By Quality Management System: Compliance Tracking, Quality Assurance And Control

8) By Tracking And Tracing System: Real-Time Tracking Of Shipments, Chain Of Custody Documentation

What Is Driving The Cell And Gene Therapy Supply Chain/Logistics Market? The Surging Demand For Cell And Gene Therapies Reshapes Supply Chain And Logistics

The increasing need for cell and gene therapies is driving the cell and gene therapy supply chain or logistics market. Cell and gene therapies are advanced medical treatments that modify cells or genes to treat diseases, offering potential breakthroughs for untreatable conditions. These cell and gene therapies need to be stored at the proper temperature and storage conditions, which can be achieved using supply chain and logistics services, which help from sourcing to distributing and storing these cell and gene therapies. For instance, according to the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, the number of gene therapies in Phase III clinical trials grew by 10% in Q3 2023, the first quarterly increase since Q3 2022. Therefore, the increasing need for cell and gene therapies drives the cell and gene therapy supply chain or logistics market forward.

What Is Driving The Cell And Gene Therapy Supply Chain/Logistics Market? Personalized Medicine Boom Drives Cell And Gene Therapy Supply Chain And Logistics Market

The increasing demand for personalized medicine is expected to propel the growth of the cell and gene therapy supply chain/logistics market going forward. Personalized medicine refers to an innovative approach to medical treatment and healthcare that tailors medical decisions, practices, interventions, and drug therapies to the individual patient. Cell and gene therapy supply chain/logistics are used to deliver safely and effectively precision medicines to meet the unique needs of individual patients with incorporate temperature monitoring to maintain the integrity throughout the supply chain. For instance, in October 2022, according to reports published by STAT, a US-based health-oriented news company, there were more than 75,000 genetic testing products and 300 personalized medicines. Therefore, the increasing demand for personalized medicine is driving the growth of the cell and gene therapy supply chain/logistics industry.

Who Are The Major Players In The Global Cell And Gene Therapy Supply Chain/Logistics Market?

Major companies operating in the cell and gene therapy supply chain/logistics market include AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.

What Are The Key Trends Of The Global Cell And Gene Therapy Supply Chain/Logistics Market? Advancements In Technology Propel Cell And Gene Therapy Logistics

Modern technology platforms are a key trend gaining popularity in the cell and gene therapy supply chain/logistics markets. Major companies operating in the market are developing modern technology platforms for cell and gene therapies to sustain their position in the market. For instance, in April 2023, AmerisourceBergen Corporation., a US-based healthcare company specializing in cell and gene therapy supply chain logistics, launched the Cell and Gene Therapy (CGT) Integration Hub. The Cell and Gene Therapy (CGT) Integration Hub is powered by AmerisourceBergen’s innovative customer relationship management (CRM) system. It can be integrated into the biopharma platform to facilitate better monitoring of the development and delivery of cell and gene therapies.

What Are The Key Trends Of The Global Cell And Gene Therapy Supply Chain/Logistics Market? Next Generation Platforms Reshaping Cell And Gene Therapy Supply Chains

Major companies operating in the cell and gene therapy supply chain and logistics are focused on introducing next-generation solutions, such as the off-the-shelf cell orchestration platform. Off-the-shelf cell orchestration platforms are platforms that provide streamlined supply chain management, pre-designed modules, industry-proven processes, quick deployment, and integration. For instance, in January 2022, TrakCel Limited, a UK-based software company, launched OCELLOS Lite. OCELLOS Lite is a pre-designed, modular, and validated solution for managing the supply chain and logistics of cell and gene therapies. It allows companies to manage supply chain processes through the clinical phases of development into commercialization and can be deployed in weeks, which makes it one of the simplest and quickest solutions.

Need data on a specific region in this market?
Request Customisation

Cell And Gene Therapy Supply Chain/Logistics Market Merger And Acquisition: Cryoport Strengthens Global Supply Chain For Regenerative Medicine Through Acquisition Of Cell And Co Bioservices

In April 2022, Cryoport Systems LLC, a US-based temperature-controlled logistics services provider, acquired Cell&Co BioServices for $6.2 million. The acquisition helped Cryoport expand its global supply chain network and meet the needs of the regenerative medicine industry. Cell&Co BioServices is a France-based supply chain management services provider for biological, pharmaceutical, and clinical samples throughout their life cycle.

Regional Outlook For The Global Cell And Gene Therapy Supply Chain/Logistics Market

North America was the largest region in the cell and gene therapy supply chain/logistics market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Cell And Gene Therapy Supply Chain/Logistics Market?

The cell and gene therapy supply chain and logistics market includes revenues earned by entities by providing sourcing and collection, quality testing, distribution, and transportation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cell And Gene Therapy Supply Chain/Logistics Industry?

The cell and gene therapy supply chain/logistics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy supply chain/logistics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Cell And Gene Therapy Supply Chain/Logistics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.57 billion
Revenue Forecast In 2034 $2.44 billion
Growth Rate CAGR of 11.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution
3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components
4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up
5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization Subsegments: 1) By Cell Orchestration Platform: Workflow Management, Scheduling And Coordination Tools
2) By Enterprise Manufacturing System: Production Planning And Control, Manufacturing Execution Systems (MES)
3) By Inventory Management System: Stock Tracking And Management, Inventory Forecasting And Optimization
4) By Laboratory Information Management System (LIMS): Sample Tracking And Management, Data Management And Reporting
5) By Logistics Management System: Route Optimization And Planning, Transportation Management 6) By Patient Management System: Patient Scheduling And Coordination, Data Management And Tracking Of Patient Outcomes 7) By Quality Management System: Compliance Tracking, Quality Assurance And Control 8) By Tracking And Tracing System: Real-Time Tracking Of Shipments, Chain Of Custody Documentation
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Cell And Gene Therapy Supply Chain/Logistics Market Characteristics

3. Cell And Gene Therapy Supply Chain/Logistics Market Trends And Strategies

4. Cell And Gene Therapy Supply Chain/Logistics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cell And Gene Therapy Supply Chain/Logistics Growth Analysis And Strategic Analysis Framework

5.1. Global Cell And Gene Therapy Supply Chain/Logistics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cell And Gene Therapy Supply Chain/Logistics Market Growth Rate Analysis

5.4. Global Cell And Gene Therapy Supply Chain/Logistics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cell And Gene Therapy Supply Chain/Logistics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cell And Gene Therapy Supply Chain/Logistics Total Addressable Market (TAM)

6. Cell And Gene Therapy Supply Chain/Logistics Market Segmentation

6.1. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cell Orchestration Platform

Enterprise Manufacturing System

Inventory Management System

Laboratory Information Management System

Logistics Management System

Patient Management System

Quality Management System

Tracking And Tracing System

6.2. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cloud-Based Solution

On-Premises Solution

6.3. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cryogenic Shippers

Cryogenic Storage Freezers

Ultra-Low Freezers

Cold Chain Management Systems

Shipment

Storage Medium

Cryogenic Packout Kits

Other Components

6.4. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Donor Eligibility Assessment

Sample Collection

Manufacturing

Logistics

Patient Verification

Treatment Follow-Up

6.5. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biobank

Cell Therapy Lab

Hospital

Research Institute

Commercial Organization

6.6. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Cell Orchestration Platform, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Workflow Management

Scheduling And Coordination Tools

6.7. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Enterprise Manufacturing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Production Planning And Control

Manufacturing Execution Systems (MES)

6.8. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Inventory Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Stock Tracking And Management

Inventory Forecasting And Optimization

6.9. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Laboratory Information Management System (LIMS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sample Tracking And Management

Data Management And Reporting

6.10. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Logistics Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Route Optimization And Planning

Transportation Management

6.11. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Patient Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Patient Scheduling And Coordination

Data Management And Tracking Of Patient Outcomes

6.12. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Quality Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Compliance Tracking

Quality Assurance And Control

6.13. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Tracking And Tracing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Real-Time Tracking Of Shipments

Chain Of Custody Documentation

7. Cell And Gene Therapy Supply Chain/Logistics Market Regional And Country Analysis

7.1. Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market

8.1. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell And Gene Therapy Supply Chain/Logistics Market

9.1. China Cell And Gene Therapy Supply Chain/Logistics Market Overview

9.2. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell And Gene Therapy Supply Chain/Logistics Market

10.1. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell And Gene Therapy Supply Chain/Logistics Market

11.1. Japan Cell And Gene Therapy Supply Chain/Logistics Market Overview

11.2. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell And Gene Therapy Supply Chain/Logistics Market

12.1. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market

13.1. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell And Gene Therapy Supply Chain/Logistics Market

14.1. South Korea Cell And Gene Therapy Supply Chain/Logistics Market Overview

14.2. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market

15.1. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market Overview

15.2. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell And Gene Therapy Supply Chain/Logistics Market

16.1. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell And Gene Therapy Supply Chain/Logistics Market

17.1. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell And Gene Therapy Supply Chain/Logistics Market

18.1. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell And Gene Therapy Supply Chain/Logistics Market

19.1. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell And Gene Therapy Supply Chain/Logistics Market

20.1. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market

21.1. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market Overview

21.2. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell And Gene Therapy Supply Chain/Logistics Market

22.1. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell And Gene Therapy Supply Chain/Logistics Market

23.1. North America Cell And Gene Therapy Supply Chain/Logistics Market Overview

23.2. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell And Gene Therapy Supply Chain/Logistics Market

24.1. USA Cell And Gene Therapy Supply Chain/Logistics Market Overview

24.2. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell And Gene Therapy Supply Chain/Logistics Market

25.1. Canada Cell And Gene Therapy Supply Chain/Logistics Market Overview

25.2. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell And Gene Therapy Supply Chain/Logistics Market

26.1. South America Cell And Gene Therapy Supply Chain/Logistics Market Overview

26.2. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell And Gene Therapy Supply Chain/Logistics Market

27.1. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell And Gene Therapy Supply Chain/Logistics Market

28.1. Middle East Cell And Gene Therapy Supply Chain/Logistics Market Overview

28.2. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell And Gene Therapy Supply Chain/Logistics Market

29.1. Africa Cell And Gene Therapy Supply Chain/Logistics Market Overview

29.2. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell And Gene Therapy Supply Chain/Logistics Market Competitive Landscape And Company Profiles

30.1. Cell And Gene Therapy Supply Chain/Logistics Market Competitive Landscape

30.2. Cell And Gene Therapy Supply Chain/Logistics Market Company Profiles

30.2.1. AmerisourceBergen Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.2. United Parcel Service Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Avantor Sciences Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

31. Cell And Gene Therapy Supply Chain/Logistics Market Other Major And Innovative Companies

31.1. Arvato Group

31.2. Catalent Inc.

31.3. Charles River Laboratories International

31.4. Parexel International Corporation

31.5. Cytiva

31.6. Almac Group

31.7. World Courier

31.8. Sharp Packaging Services

31.9. PCI Pharma Services

31.10. Cryoport Inc.

31.11. Brooks Life Sciences

31.12. BioLife Solutions Inc.

31.13. Biocair Inc.

31.14. QuickSTAT

31.15. Clarkston Consulting Inc.

32. Global Cell And Gene Therapy Supply Chain/Logistics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell And Gene Therapy Supply Chain/Logistics Market

34. Recent Developments In The Cell And Gene Therapy Supply Chain/Logistics Market

35. Cell And Gene Therapy Supply Chain/Logistics Market High Potential Countries, Segments and Strategies

35.1 Cell And Gene Therapy Supply Chain/Logistics Market In 2029 - Countries Offering Most New Opportunities

35.2 Cell And Gene Therapy Supply Chain/Logistics Market In 2029 - Segments Offering Most New Opportunities

35.3 Cell And Gene Therapy Supply Chain/Logistics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Cell Orchestration Platform, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Enterprise Manufacturing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Inventory Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Laboratory Information Management System (LIMS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Logistics Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Patient Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Quality Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Tracking And Tracing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 83: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 84: AmerisourceBergen Corporation Financial Performance
  • Table 85: United Parcel Service Financial Performance
  • Table 86: Thermo Fisher Scientific Inc. Financial Performance
  • Table 87: Avantor Sciences Financial Performance
  • Table 88: Lonza Group AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Cell Orchestration Platform, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Enterprise Manufacturing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Inventory Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Laboratory Information Management System (LIMS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Logistics Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Patient Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Quality Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Tracking And Tracing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 83: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 84: AmerisourceBergen Corporation Financial Performance
  • Figure 85: United Parcel Service Financial Performance
  • Figure 86: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 87: Avantor Sciences Financial Performance
  • Figure 88: Lonza Group AG Financial Performance

$5.62 Billion Forecast for Liver Cancer Market by 2029, Backed by Demand and Innovation

Read More About $5.62 Billion Forecast for Liver Cancer Market by 2029, Backed by Demand and Innovation

Lupus Nephritis Market Valuation Expected To Reach $2.78 Billion By 2029, Growing At A Rate Of 7.5%

Read More About Lupus Nephritis Market Valuation Expected To Reach $2.78 Billion By 2029, Growing At A Rate Of 7.5%

Strong CAGR to Propel in the Malignant Mesothelioma Market and Beyond upto $3.32 Billion by 2029

Read More About Strong CAGR to Propel in the Malignant Mesothelioma Market and Beyond upto $3.32 Billion by 2029

Malignant Pleural Effusion Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Read More About Malignant Pleural Effusion Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Active Implantable Medical Devices Market 2023 – By Product Type (Cardiac Pacemakers, Implantable Cardioverter Defibrillators (ICD), Nerve Simulators, Cochlear Implants, Ventricular Assist Devices, Other Products), By Ap...

View Report

Gene Therapy Global Market Report 2025 – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis, Neurologi...

View Report

K-Beauty Products Global Market Report 2025 – By Product Type (Skin Care, Hair Care), By Distribution Channel ( Supermarkets And Hypermarkets, Specialty Stores, Online, Pharmacies), By End-User (Men, Women) – Impact of T...

View Report

Generative AI In Creative Industries Global Market Report 2025 – By Type (Text-To-Image Generation, Image-To-Image Generation, Music Generation, Video Generation, 3D Modeling and Animation), By Deployment Mode (On-Premis...

View Report

Platelet Aggregation Devices Global Market Report 2025 – By Product (Reagents, Systems, Consumables And Accessories), By Type ( Four Channel, Dual Channel, Eight Channel), By Technology (Optical, Impedance, Other Technol...

View Report

Retail Digital Transformation Global Market Report 2025 – By Accessibility (Mobile Application, Website), By Technology (Cloud Computing, Big Data, Artificial intelligence, Internet Of Things (IoT), Augmented Reality (AR...

View Report

Frequently Asked Questions

Cell and gene therapy supply chains and logistics refer to the processes and activities involved in efficiently and effectively managing the flow of materials, information, and resources needed to develop, manufacture, and distribute cell and gene therapies from their initial production to their final administration to patients. These services provide cutting-edge treatments to patients while maintaining the highest safety and efficacy standards throughout the supply chain. For further insights on this market, request a sample here

The market major growth driver - The Surging Demand For Cell And Gene Therapies Reshapes Supply Chain And Logistics. For further insights on this market, request a sample here

The cell and gene therapy supply chain/logistics market size has grown rapidly in recent years. It will grow from $1.41 billion in 2024 to $1.57 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to growth in prevalence of chronic diseases, efficient use of supply chain requirements, rise in maintenance the drug integrity, evolved regulatory frameworks, increased emphasis on risk mitigation and compliance. The cell and gene therapy supply chain/logistics market size is expected to see rapid growth in the next few years. It will grow to " $2.44 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to expansion of personalized medicine, development of cell-free therapies, growing prevalence of chronic diseases, growing global cell therapy manufacturing market, efficient use of supply chain requirements. Major trends in the forecast period include increased research and development expenditure, adoption of advanced technologies, favorable initiatives and programs for easier access, partnerships and collaborations between cell and gene therapy companies, supply chain providers, and logistics companies, providing of customizable services to support any point of patient identification. For further insights on this market, request a sample here

The cell and gene therapy supply chain/logisticsmarket covered in this report is segmented –
1) By Type Of Software Solution: Cell Orchestration Platform; Enterprise Manufacturing System; Inventory Management System; Laboratory Information Management System; Logistics Management System; Patient Management System; Quality Management System; Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution; On-Premises Solution
3) By Component: Cryogenic Shippers; Cryogenic Storage Freezers; Ultra-Low Freezers; Cold Chain Management Systems; Shipment; Storage Medium; Cryogenic Packout Kits; Other Components
4) By Application Area: Donor Eligibility Assessment; Sample Collection; Manufacturing; Logistics; Patient Verification; Treatment Follow-Up
5) By End User: Biobank; Cell Therapy Lab; Hospital; Research Institute; Commercial Organization Subsegments:
1) By Cell Orchestration Platform: Workflow Management; Scheduling And Coordination Tools
2) By Enterprise Manufacturing System: Production Planning And Control; Manufacturing Execution Systems (MES)
3) By Inventory Management System: Stock Tracking And Management; Inventory Forecasting And Optimization
4) By Laboratory Information Management System (LIMS): Sample Tracking And Management; Data Management And Reporting
5) By Logistics Management System: Route Optimization And Planning; Transportation Management
6) By Patient Management System: Patient Scheduling And Coordination; Data Management And Tracking Of Patient Outcomes
7) By Quality Management System: Compliance Tracking; Quality Assurance And Control
8) By Tracking And Tracing System: Real-Time Tracking Of Shipments; Chain Of Custody Documentation For further insights on this market, request a sample here

North America was the largest region in the cell and gene therapy supply chain/logistics market in 2024. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the cell and gene therapy supply chain/logistics market include AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd. . For further insights on this market, request a sample here.

Major trends in this market include Advancements In Technology Propel Cell And Gene Therapy Logistics. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Cell And Gene Therapy Supply Chain/Logistics Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon